top of page
7/02/2017
The first Newsletter produced by NIC’s 2017 team is finally out! Do not miss this month’s detailed analysis on the Novo Nordisk and McDonald’s. Take a look on how our Financial Markets’ analysts have been facing the uncertainty over the Trump’s most recent policies.
Finally, our IBD analyst Tomás Costa invites to analyse Basel III implications for the future.
Check it out here!
bottom of page